Bio Rad Laboratories Inc
NYSE:BIO
Bio Rad Laboratories Inc
NYSE:BIO
Price:
289.81 USD
1.53%
Updated:
May 14, 2024
EV/IC
Enterprise Value to IC
Enterprise Value to IC
0.7
Current
1.2
Median
2.4
Industry
Lower
than median
Lower
than industry value
Enterprise Value to Invested Capital (EV/IC) ratio is a valuation multiple that measures the dollars in Enterprise Value for each dollar of capital invested by shareholders and lenders.
EV/IC
=0.7
Enterprise Value
/
7.8B
Invested Capital
10.9B
All Countries
| Market Cap | EV/IC | ||||
|---|---|---|---|---|---|
| US |
|
Bio Rad Laboratories Inc
NYSE:BIO
|
8.3B USD | 0.7 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
229.7B USD | 2.9 | |
| US |
|
Danaher Corp
NYSE:DHR
|
189.8B USD | 2.6 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
44.2B USD | 5.1 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
41.9B USD | 2.5 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
36.7B CHF | 2.6 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
55.6T KRW | 3.9 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
31.8B USD | 11.1 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
26.2B USD | 9.3 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
25.9B USD | 1.7 | |
| US |
|
Waters Corp
NYSE:WAT
|
21.2B USD | 5.5 |
EV/IC Forward Multiples
Forward EV/IC multiple is a version of the EV/IC ratio that uses forecasted invested capital for the EV/IC calculation. 1-Year, 2-Years, and 3-Years forwards use invested capital forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/IC
N/A
2-Years Forward
EV/IC
N/A
3-Years Forward
EV/IC
N/A
You don't have any saved screeners yet
